John Moriarity, MD
Neurological Surgery · Flowood, MSNPI 1437105194
Payments from drug & device makers
What this record shows
Globus Medical accounts for 63.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,120, more than ten times the $13 reported in 2019. That places this record below the midpoint for neurological surgery clinicians in MS, where the typical reported total is $2,311.
Across 14 payments — averaging $120.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$1K
- Angiodynamics, Inc.$399
- Penumbra, Inc.$147
- Convatec Inc.$40
- Medline Industries LP$27
Across 2 payments — averaging $57,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$116K
What the payments were for
- Travel & lodging$96557%
- Food & beverage$72843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 9 | $1,080 |
| Angiodynamics, Inc. | 1 | $399 |
| Penumbra, Inc. | 1 | $147 |
| Convatec Inc. | 1 | $40 |
| Medline Industries LP | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Excelsius - GPS$858
- AngioVac$399
- Penumbra System$147
How this compares
$1,693 in reported general payments places this provider in the 45th percentile of 54 neurological surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 103 | $699 |
| Methylprednisolone | 75 | $443 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $219 |
| Tramadol Hcl | 37 | $114 |
| Cyclobenzaprine Hcl | 14 | $68 |
| Tamsulosin Hcl | 20 | $8 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Flowood
- Edward CullomFlowood$10K
- Kelsey WalshFlowood$9K
- Matthew VanlandinghamFlowood$6K
- Eric AmundsonFlowood$2K
- Orhan IlercilFlowood$699
- John NeillFlowood$668
- Philip AzordeganFlowood$253
- John DavisFlowood$115
- Danielle PhillipsFlowood$106
- Walton StringerFlowood$66
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.